SCHEMBL25909328

SCHEMBL25909328

Cc1ccc2c(c1)C1(CCN(CCOc3cnc(S(C)(=O)=O)c(C)c3)CC1)C(=O)N2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
MAPT P10636 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35
GRIN2C Q14957 1/20 0.35
GRIN3A Q8TCU5 1/20 0.35
HTR1A P08908 5/20 0.35
HTR2A P28223 5/20 0.35
HTR7 P34969 5/20 0.35
HTR6 P50406 5/20 0.35
DRD3 P35462 4/20 0.34
DRD2 P14416 3/20 0.34
MAPK14 Q16539 1/20 0.34
PIK3CD O00329 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ADRA2B P18089 1/20 0.34
FLT3 P36888 1/20 0.34
ACHE P22303 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25314455 0.91 IP6K1 (0.40) HTR1AHTR2AHTR7HTR6SMN1; SMN2
SCHEMBL30507370 0.91 IP6K1 (0.40) HTR1AHTR2AHTR7HTR6SMN1; SMN2
SCHEMBL25312899 0.89 ALK (0.39) MAPT
SCHEMBL25932252 0.87 HTR1A (0.37) GRIN2DGRIN3BMAPTGRIN1GRIN2A
SCHEMBL25317378 0.84 HRH3 (0.44) GRIN2DGRIN3BMAPTGRIN1GRIN2A
SCHEMBL26048605 0.80 DRD2 (0.36) HTR1AHTR2AHTR7DRD3DRD2
SCHEMBL25932861 0.80 KDM4E (0.41) HTR1AHTR2AHTR7HTR6DRD3
SCHEMBL25908655 0.80 GPR119 (0.41) HTR1AHTR2AHTR7HTR6DRD3
SCHEMBL25912010 0.80 DRD3 (0.37) GRIN2DGRIN3BMAPTGRIN1GRIN2A
SCHEMBL26044329 0.79 PGR (0.39) ADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141432-A2 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2023-07-27 WO disclosed